XML 17 R6.htm IDEA: XBRL DOCUMENT v3.19.2
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS’ EQUITY - USD ($)
$ in Thousands
Shares of Common Stock
Common Stock and Additional Paid in Capital
Retained Earnings
Accumulated Other Comprehensive Income (Loss)
Total
Balance, beginning of period at Dec. 31, 2017   $ 61,981 $ 19,711 $ (292) $ 81,400
Balance (in shares) at Dec. 31, 2017 6,294,930        
Increase (Decrease) in Shareholders' Equity          
Net income for period     1,933   1,933
Other comprehensive income          
Net unrealized gain on securities available for sale       677 677
Total comprehensive income     1,933 677 2,610
Stock compensation   274     274
Restricted stock award vesting (in shares) 45,630        
FFNM acquisition   34,101     34,101
FFNM acquisition (in shares) 2,146,378        
Capital raise, net of offering costs   32,524     32,524
Capital raise, net of offering costs (in shares) 2,225,807        
Dividend on common stock     (2,042)   (2,042)
Balance, end of period at Jun. 30, 2018   128,880 19,602 385 148,867
Balance (in shares) at Jun. 30, 2018 10,712,745        
Balance, beginning of period at Mar. 31, 2018   62,080 20,493 (716) 81,857
Balance (in shares) at Mar. 31, 2018 6,332,560        
Increase (Decrease) in Shareholders' Equity          
Net income for period     396   396
Other comprehensive income          
Net unrealized gain on securities available for sale       1,101 1,101
Total comprehensive income     396 1,101 1,497
Stock compensation   175     175
Restricted stock award vesting (in shares) 8,000        
FFNM acquisition   34,101     34,101
FFNM acquisition (in shares) 2,146,378        
Capital raise, net of offering costs   32,524     32,524
Capital raise, net of offering costs (in shares) 2,225,807        
Dividend on common stock     (1,287)   (1,287)
Balance, end of period at Jun. 30, 2018   128,880 19,602 385 148,867
Balance (in shares) at Jun. 30, 2018 10,712,745        
Balance, beginning of period at Dec. 31, 2018   129,066 23,466 (463) 152,069
Balance (in shares) at Dec. 31, 2018 10,712,745        
Increase (Decrease) in Shareholders' Equity          
Net income for period     6,836   6,836
Other comprehensive income          
Net unrealized gain on securities available for sale       1,307 1,307
Total comprehensive income     6,836 1,307 8,143
Stock compensation   196     196
Restricted stock award vesting (in shares) 27,967        
Dividend on common stock     (2,568)   (2,568)
Balance, end of period at Jun. 30, 2019   129,262 27,734 844 157,840
Balance (in shares) at Jun. 30, 2019 10,740,712        
Balance, beginning of period at Mar. 31, 2019   129,204 25,347 195 154,746
Balance (in shares) at Mar. 31, 2019 10,740,712        
Increase (Decrease) in Shareholders' Equity          
Net income for period     3,669   3,669
Other comprehensive income          
Net unrealized gain on securities available for sale       649 649
Total comprehensive income     3,669 649 4,318
Stock compensation   58     58
Dividend on common stock     (1,282)   (1,282)
Balance, end of period at Jun. 30, 2019   $ 129,262 $ 27,734 $ 844 $ 157,840
Balance (in shares) at Jun. 30, 2019 10,740,712